Published in Medicine and Law Weekly, October 15th, 2004
Millman has more than 25 years of experience in the biotechnology sector, and he has served as a consultant for Alnylam since June 2003.
In his position at Alnylam, Millman will be responsible for directing all aspects of the company's intellectual property activities, and will be a member of the company's management team.
"We are delighted to formally welcome Robert to our team," commented Barry Greene, chief operating officer of Alnylam. "He has demonstrated leadership and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.